Navigation Links
MSU researcher awarded $2 million to tackle parasitic tropical diseases
Date:2/4/2010

EAST LANSING, Mich. In an effort to eliminate the tropical diseases elephantiasis and river blindness, a Michigan State University researcher has been awarded $2 million to reformulate an existing drug that could stop the debilitating diseases in their tracks.

Charles Mackenzie, a professor of veterinary pathology in the College of Veterinary Medicine, was awarded the funding via a larger $13 million grant the Washington University School of Medicine in St. Louis received from the Bill & Melinda Gates Foundation.

Elephantiasis (lymphatic filariasis) and river blindness (onchocerciasis) known as filarial diseases, in which the body is infected with parasitic worms afflict about 140 million people worldwide, doing much of its damage in equatorial Africa.

Elephantiasis, caused by tiny worms spread via mosquitoes, results in severe swelling of the legs, arms and torso. River blindness is spread by black flies, and after the parasitic worms die in a person's eye, can cause blindness and debilitating skin disease.

Mackenzie, who has been studying filarial diseases for more than 30 years and has done extensive work in Tanzania and Ecuador, is focusing on flubendazole. The drug was used in the 1980s with good results against filarial worms when it was injected in animals and humans. However, the injections caused severe abscesses and lost effectiveness outside of the digestive system.

"We think the oil the drug was dissolved in before administering it may have caused the reactions," Mackenzie said. "We are working now to develop a new way to safely administer this medicine."

Since the medicine targets the adult parasitic worms so well, Mackenzie is confident that developing a safe way to deliver it would have a huge impact.

"The technology we have today is leaps and bounds ahead of what we were using in the 1980s," he said. "If we can reformulate the drug and easily administer it, we can make meeting the World Health Organization's goal of eradicating filarial diseases a reality."

MSU, Washington University, Case Western Reserve University in Cleveland and McGill University in Montreal are all working on projects with funding from the grant and together form the Filariasis University Consortium. In addition to the work Mackenzie is doing at MSU with cooperation from McGill, the overall grant will fund two other projects:

*Researchers at Washington University will test the costs and benefits of twice-yearly mass drug administration versus the currently standard annual treatment. The project will include two regions in equatorial Africa where persons with lymphatic filariasis also may be infected with another filarial worm that previously prevented mass drug administration programs from occurring. MSU along with its Tanzanian colleagues will be part of these field trials.

*Scientists at Case Western will conduct two clinical trials of different treatments for lymphatic filariasis and one trial of new treatments for onchocerciasis. The scientists will take existing drugs and give them in different doses and combinations to see if they are more effective than current treatments.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert

Related biology news :

1. Secrets to superb malting barleys explored by ARS researchers
2. UF researchers: Ancient crocodile relative likely food source for Titanoboa
3. ARS researchers develop method to speed up breeding of scab-resistant barley cultivars
4. Ability to navigate may be linked to genes, researcher says
5. MSU researcher identifies cell mechanism leading to diabetic blindness
6. Boston University School of Medicine researcher awarded the 2010 Avanti Award in Lipids
7. National Jewish Health researchers discover how virulent bacteria
8. Epigenetics could help researchers determine any risks associated with low-dose radiation
9. University of the Basque Country researchers decode transcriptome for gray mullet
10. Researchers correct the record about behavior of important human protein tied to cancer
11. Bat researchers no longer flying blind on echolocation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
Breaking Biology Technology: